Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors

Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European urology 2021-07, Vol.80 (1), p.113-113
1. Verfasser: Alfred Witjes, J.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 113
container_issue 1
container_start_page 113
container_title European urology
container_volume 80
creator Alfred Witjes, J.
description
doi_str_mv 10.1016/j.eururo.2021.02.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2528508694</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0302283821000919</els_id><sourcerecordid>2528508694</sourcerecordid><originalsourceid>FETCH-LOGICAL-c226t-53371d4402e61eab3b62a6bbb1156ca9ac80d9c31ca21c395fd031a7f534a5d03</originalsourceid><addsrcrecordid>eNp9UcGO0zAQtRCILQt_gJCPXBLGduwkHJBQl4WVuqJa2LPlOJOtqzQuthPEF_DbuOrCkdMbzbw3TzOPkNcMSgZMvduXOIc5-JIDZyXwEqB-QlasqUVRSwVPyQoE8II3orkgL2LcA4CQrXhOLsQJlVQr8vsO39Nrt2AxGJt8oNvgHyYfk7P01vc40iE3v81hcYsZqR_oNg-L42iSm-YD3WbEKUX606UdvcVkYjIn8X3waYejy6K1CdZN_mDoHVp0i5se6Paq2DB6M-1c57JtfEmeDWaM-OoRL8n99afv6y_F5uvnm_XHTWE5V6mQQtSsryrgqBiaTnSKG9V1HWNSWdMa20DfWsGs4cyKVg49CGbqQYrKyFxfkrfnvcfgf8wYkz64aHEczYR-jppL3khoVFtlanWm2uBjDDjoY3AHE35pBvoUgd7rcwT6FIEGrnMEWfbm0WHuDtj_E_39eSZ8OBMw37k4DDra_EOLvQtok-69-7_DH41bm14</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2528508694</pqid></control><display><type>article</type><title>Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors</title><source>Elsevier ScienceDirect Journals</source><creator>Alfred Witjes, J.</creator><creatorcontrib>Alfred Witjes, J.</creatorcontrib><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/j.eururo.2021.02.007</identifier><identifier>PMID: 33593656</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><ispartof>European urology, 2021-07, Vol.80 (1), p.113-113</ispartof><rights>2021 European Association of Urology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c226t-53371d4402e61eab3b62a6bbb1156ca9ac80d9c31ca21c395fd031a7f534a5d03</cites><orcidid>0000-0003-0059-3857</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.eururo.2021.02.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33593656$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alfred Witjes, J.</creatorcontrib><title>Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors</title><title>European urology</title><addtitle>Eur Urol</addtitle><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9UcGO0zAQtRCILQt_gJCPXBLGduwkHJBQl4WVuqJa2LPlOJOtqzQuthPEF_DbuOrCkdMbzbw3TzOPkNcMSgZMvduXOIc5-JIDZyXwEqB-QlasqUVRSwVPyQoE8II3orkgL2LcA4CQrXhOLsQJlVQr8vsO39Nrt2AxGJt8oNvgHyYfk7P01vc40iE3v81hcYsZqR_oNg-L42iSm-YD3WbEKUX606UdvcVkYjIn8X3waYejy6K1CdZN_mDoHVp0i5se6Paq2DB6M-1c57JtfEmeDWaM-OoRL8n99afv6y_F5uvnm_XHTWE5V6mQQtSsryrgqBiaTnSKG9V1HWNSWdMa20DfWsGs4cyKVg49CGbqQYrKyFxfkrfnvcfgf8wYkz64aHEczYR-jppL3khoVFtlanWm2uBjDDjoY3AHE35pBvoUgd7rcwT6FIEGrnMEWfbm0WHuDtj_E_39eSZ8OBMw37k4DDra_EOLvQtok-69-7_DH41bm14</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Alfred Witjes, J.</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0059-3857</orcidid></search><sort><creationdate>20210701</creationdate><title>Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors</title><author>Alfred Witjes, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c226t-53371d4402e61eab3b62a6bbb1156ca9ac80d9c31ca21c395fd031a7f534a5d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alfred Witjes, J.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alfred Witjes, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>80</volume><issue>1</issue><spage>113</spage><epage>113</epage><pages>113-113</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>33593656</pmid><doi>10.1016/j.eururo.2021.02.007</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-0059-3857</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0302-2838
ispartof European urology, 2021-07, Vol.80 (1), p.113-113
issn 0302-2838
1873-7560
language eng
recordid cdi_proquest_miscellaneous_2528508694
source Elsevier ScienceDirect Journals
title Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T22%3A34%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Re:%20Five-factor%20Prognostic%20Model%20for%20Survival%20of%20Post-platinum%20Patients%20with%20Metastatic%20Urothelial%20Carcinoma%20Receiving%20PD-L1%20Inhibitors&rft.jtitle=European%20urology&rft.au=Alfred%20Witjes,%20J.&rft.date=2021-07-01&rft.volume=80&rft.issue=1&rft.spage=113&rft.epage=113&rft.pages=113-113&rft.issn=0302-2838&rft.eissn=1873-7560&rft_id=info:doi/10.1016/j.eururo.2021.02.007&rft_dat=%3Cproquest_cross%3E2528508694%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2528508694&rft_id=info:pmid/33593656&rft_els_id=S0302283821000919&rfr_iscdi=true